Enhancement of efficacy of tuberculosis drugs with Immunoxel (Dzherelo) in HIV-infected patients with active pulmonary tuberculosis

Immunotherapy
Olga V ArjanovaGalyna A Kutsyna

Abstract

Immunoxel (Dzherelo) is an oral, herbal immunomodulator used in Ukraine for adjunct therapy of infectious and autoimmune diseases. Antiretroviral drug-naive, tuberculosis (TB)/HIV coinfected patients with active pulmonary TB were divided into two arms, A (n = 20) and B (n = 20), to receive first-line anti-TB therapy (ATT) or ATT + Dzherelo, respectively. As a result, three (16%) versus 12 (67%; p = 0.003) patients had Mycobacterium tuberculosis culture conversion, with time to negative culture of 6 and 4 months in arms A and B, respectively. In the ATT-alone arm, the healing of pulmonary cavitations was observed in 25% of patients at weeks 24-28, while 60% of individuals in arm B healed at 16-18 weeks (p = 0.025). The TB lesions, on chest x-ray, had cleared in 46 and 84%, with time-to-clearance of 24-28 and 16-18 weeks in arms A and B, respectively. In the ATT-alone arm, the bodyweight at baseline was 64 +/- 6.3 kg, with 13 cachexic patients who had an average weight deficit of -5.2 +/- 1.7 kg. At the end of 6 months of follow-up, they have lost an additional 0.6 kg (-5.8 +/- 2.4). The study entry-level weight in arm B was 52 +/- 5.7 kg, with 12 individuals who had a body mass deficit of -8.5 +/- 2.7 kg. The immunotherapeutic i...Continue Reading

Associated Clinical Trials

References

Aug 5, 2000·Phytotherapy Research : PTR·S M NewtonC W Wright
Nov 17, 2004·Current Pharmaceutical Design·Haruaki Tomioka
Feb 18, 2005·The Journal of Infectious Diseases·Harriet Mayanja-KizzaUNKNOWN Uganda-Case Western Research Collaboration
Jun 14, 2005·International Journal of STD & AIDS·F DrobniewskiS Servetsky
Oct 4, 2005·Nature Reviews. Immunology·Paul NunnMario Raviglione
May 18, 2006·Emerging Infectious Diseases·Marieke J van der WerfLeonid V Turchenko
Mar 3, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·V V NikolayevskyyF A Drobniewski
Aug 24, 2007·Expert Opinion on Investigational Drugs·Jianping Liu
Apr 30, 2008·International Immunopharmacology·Lyudmila G NikolaevaGalyna A Kutsyna

❮ Previous
Next ❯

Software Mentioned

STATMOST
Likopid

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.